Delivery Order SPE2DB22D3501-SPE2DB25FWV23
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,905.08 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This contract, awarded on August 8, 2025, with a completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,120.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed price delivery order was awarded on a competitive basis with no set-aside designation. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $9,837.09. This is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, utilizing no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $36,331.88 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity: 30 units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement of pharmaceutical supplies for federal medical needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $16,566.76 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 12, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $22,737.60 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) under a firm fixed price contract. This delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a non-competitive set-aside award to support federal pharmaceutical procurement needs. The pharmaceutical product will be performed and distributed from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $6,905.67 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in a 30-count unit package. This competitively awarded, firm fixed-price delivery order was issued on April 22, 2025, with an ultimate completion date of April 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,541.35 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was competitively awarded with no set-aside designation, and performance will be executed from...
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $37,649.28 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract is scheduled for ultimate completion by July 30, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWV23Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,392.88 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger relationship with the federal government as a critical pharmaceutical distributor. This delivery order is a child contract issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime vendor in the DLA Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical commodities to support military and veteran healthcare systems. The company was selected through competitive procurement and demonstrates substantial capacity to fulfill federal medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 8/12/25 |